Bone Marrow Necrosis: An Unusual Misdiagnosed Serious Complication
Journal Title: International Journal of Blood Research and Disorders - Year 2017, Vol 4, Issue 1
Abstract
Bone Marrow Necrosis (BMN) is an uncommon syndrome characterized by destruction of hematopoietic tissue with preservation of the bone. It presents as localized or diffuse generalized process. Many underlying diseases can lead to marrow necrosis: most commonly malignancies and rarely sickle cell disease. Although there are no clinical nor laboratory pathognomonic signs, clinicians must keep a high index of suspicion whenever there is fever, severe bone pain, elevated lactate dehydrogenase, and anemia. Bone marrow biopsy remains the mainstay of the diagnosis. BMN associated with sickle cell disease is usually of better prognosis compared to BMN secondary to malignancies.
Significance of sCD86 Levels in Acute Myelogenous Leukemia Patients: An Egyptian Study
The prognostic significance of sCD86 in patients with hematologic malignancies is unclear. We evaluated sCD86 levels in 63 newly diagnosed AML and 16 controls by enzyme-linked immunosorbent assay and then analyzed how it...
Zika Induced Meningoencephalitis in a Ruxolitinib Treated Patient with Secondary Myelofibrosis
We describe here the first case of a patient with post-ET myelofibrosis treated with ruxolitinib at French West Indies complicated with zika induced meningoencephalitis. Patient presented with fever, confusion along with...
Polycythemia Vera with High Erythropoietin Level: Case Report
Polycythemia Vera (PV) is a myeloproliferative disorder of bone marrow stem cells characterized by erythrocytosis. Elevated erythropoietin level strongly indicates secondary erythrocytosis and excludes PV diagnosis. Howe...
Chronic Use of Adalimumab as Potential Cause of Severe Thrombocytopenia in Psoriatic Arthritis Patient: The Need for Regular Monitoring of Cytopenias
Anti-tumor necrosis factor alpha (anti-TNFα) agents are used to treat inflammatory diseases with recognized safety and efficacy. Although they are rare, severe hematologic adverse effects are described and may be fatal....
Successful Treatment of a Primary Cervical Diffuse Large B-cell Lymphoma with Rituximab-CHOP Immunochemotherapy
Introduction: Primary Large B-cell lymphoma of the cervix is a very rare disease. Because of the rarity of this tumor, it can lead to mistakes or delays in the diagnosis and proper therapy, and eventually becoming diagno...